Market Mover: Krystal (KRYS) Gains at Midday June 22

Equities Staff  |

Krystal Biotech Inc (NASDAQ: KRYS) has climbed $4.365 (7.15%) and is currently sitting at $65.56, as of 12:02:09 est on June 22.

154,635 shares have traded hands.

The Company is up 21.01% over the last 5 days and shares have risen 3.42% over the last 30 days.

Krystal anticipates its next earnings on 2022-08-08.

For technical charts, analysis, and more on Krystal visit the company profile.

About Krystal Biotech Inc

Krystal Biotech, Inc. is a pivotal-stage gene therapy company leveraging its novel, redosable gene therapy platform and in-house manufacturing capabilities to develop therapies to treat serious rare diseases.

To get more information on Krystal Biotech Inc and to follow the company's latest updates, you can visit the company's profile page here: Krystal Biotech Inc's Profile. For more news on the financial markets be sure to visit Equities News. Also, don't forget to sign-up for the Daily Fix to receive the best stories to your inbox 5 days a week.

Sources: Symbol info widget is provided by TradingView based on 15-minute-delayed prices. All other article data is provided by IEX Cloud on 15-minute delayed prices or EOD company info.

Stock price data is provided by IEX Cloud on a 15-minute delayed basis. Chart price data is provided by TradingView on a 15-minute delayed basis.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer


Trending Articles

Investors Must Understand 5G Wireless Growth Wave: Jeff Kagan
'Goldilocks' Stocks Will Define This Decade
What You Need To Know About Bear Markets
Is Your iPhone Already Obsolete?



Market Movers

Sponsored Financial Content